{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:50:37Z","timestamp":1793397037480,"version":"4.5.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06398-2","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T05:32:45Z","timestamp":1745645565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recent advances in TAM mechanisms in lung diseases"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiaqi","family":"Ban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4573-7260","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"4","key":"6398_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri3166","volume":"12","author":"TJ Braciale","year":"2012","unstructured":"Braciale TJ, Sun J, Kim TS. Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol. 2012;12(4):295\u2013305. https:\/\/doi.org\/10.1038\/nri3166.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"6398_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"6398_CR3","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1172\/JCI83147","volume":"126","author":"A Gaggar","year":"2016","unstructured":"Gaggar A, Weathington N. Bioactive extracellular matrix fragments in lung health and disease. J Clin Invest. 2016;126(9):3176\u201384. https:\/\/doi.org\/10.1172\/JCI83147.","journal-title":"J Clin Invest"},{"issue":"148","key":"6398_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0033-2018","volume":"27","author":"C Upagupta","year":"2018","unstructured":"Upagupta C, Shimbori C, Alsilmi R, Kolb M. Matrix abnormalities in pulmonary fibrosis. Eur Respir Rev Off J Eur Respir Soc. 2018;27(148): 180033. https:\/\/doi.org\/10.1183\/16000617.0033-2018.","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"issue":"3","key":"6398_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3892\/ijo.2019.4850","volume":"55","author":"L Jiang","year":"2019","unstructured":"Jiang L, Li Z, Wang R. Long non-coding RNAs in lung cancer: regulation patterns, biologic function and diagnosis implications (Review). Int J Oncol. 2019;55(3):585\u201396. https:\/\/doi.org\/10.3892\/ijo.2019.4850.","journal-title":"Int J Oncol"},{"issue":"11","key":"6398_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41571-023-00813-7","volume":"20","author":"D DeRyckere","year":"2023","unstructured":"DeRyckere D, Huelse JM, Earp HS, Graham DK. TAM family kinases as therapeutic targets at the interface of cancer and immunity. Nat Rev Clin Oncol. 2023;20(11):755\u201379. https:\/\/doi.org\/10.1038\/s41571-023-00813-7.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"6398_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.113","volume":"8","author":"G Wu","year":"2017","unstructured":"Wu G, Ma Z, Hu W, et al. Molecular insights of Gas6\/TAM in cancer development and therapy. Cell Death Dis. 2017;8(3): e2700. https:\/\/doi.org\/10.1038\/cddis.2017.113.","journal-title":"Cell Death Dis"},{"key":"6398_CR8","doi-asserted-by":"publisher","unstructured":"Rizzi M, Tonello S, Dnghia D, Sainaghi PP. Gas6\/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients. Int J Mol Sci. 2023;24(2): 951. https:\/\/doi.org\/10.3390\/ijms24020951","DOI":"10.3390\/ijms24020951"},{"issue":"20","key":"6398_CR9","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.3390\/ijms20205070","volume":"20","author":"M Bellan","year":"2019","unstructured":"Bellan M, Cittone MG, Tonello S, et al. Gas6\/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis. Int J Mol Sci. 2019;20(20):5070. https:\/\/doi.org\/10.3390\/ijms20205070.","journal-title":"Int J Mol Sci"},{"issue":"724","key":"6398_CR10","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1126\/scisignal.abd2533","volume":"15","author":"M Fukatsu","year":"2022","unstructured":"Fukatsu M, Ohkawara H, Wang X, et al. The suppressive effects of Mer inhibition on inflammatory responses in the pathogenesis of LPS-induced ALI\/ARDS. Sci Signal. 2022;15(724):2533. https:\/\/doi.org\/10.1126\/scisignal.abd2533.","journal-title":"Sci Signal."},{"issue":"11","key":"6398_CR11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1164\/rccm.201707-1519OC","volume":"197","author":"MS Espindola","year":"2018","unstructured":"Espindola MS, Habiel DM, Narayanan R, et al. Targeting of TAM receptors ameliorates fibrotic mechanisms in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2018;197(11):1443\u201356. https:\/\/doi.org\/10.1164\/rccm.201707-1519OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"6398_CR12","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse C, Tabib T, Sembrat J, et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur Respir J. 2019;54(2):1802441. https:\/\/doi.org\/10.1183\/13993003.02441-2018.","journal-title":"Eur Respir J"},{"issue":"3","key":"6398_CR13","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3892\/ol.2017.7694","volume":"15","author":"G Zhang","year":"2018","unstructured":"Zhang G, Wang M, Zhao H, Cui W. Function of Axl receptor tyrosine kinase in non-small cell lung cancer. Oncol Lett. 2018;15(3):2726\u201334. https:\/\/doi.org\/10.3892\/ol.2017.7694.","journal-title":"Oncol Lett"},{"issue":"1","key":"6398_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1128\/MCB.00764-14","volume":"35","author":"A Abu-Thuraia","year":"2015","unstructured":"Abu-Thuraia A, Gauthier R, Chidiac R, et al. Axl phosphorylates Elmo scaffold proteins to promote Rac activation and cell invasion. Mol Cell Biol. 2015;35(1):76\u201387. https:\/\/doi.org\/10.1128\/MCB.00764-14.","journal-title":"Mol Cell Biol"},{"key":"6398_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.freeradbiomed.2013.09.011","volume":"65","author":"JS Huang","year":"2013","unstructured":"Huang JS, Cho CY, Hong CC, et al. Oxidative stress enhances Axl-mediated cell migration through an Akt1\/Rac1-dependent mechanism. Free Radic Biol Med. 2013;65:1246\u201356. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.09.011.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"6398_CR16","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1593\/neo.05640","volume":"7","author":"YS Shieh","year":"2005","unstructured":"Shieh YS, Lai CY, Kao YR, et al. Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia N Y N. 2005;7(12):1058\u201364. https:\/\/doi.org\/10.1593\/neo.05640.","journal-title":"Neoplasia N Y N"},{"issue":"8","key":"6398_CR17","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1158\/0008-5472.CAN-06-3191","volume":"67","author":"JD Lay","year":"2007","unstructured":"Lay JD, Hong CC, Huang JS, et al. Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res. 2007;67(8):3878\u201387. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3191.","journal-title":"Cancer Res"},{"issue":"19","key":"6398_CR18","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1158\/1078-0432.CCR-12-1451","volume":"19","author":"CT Cummings","year":"2013","unstructured":"Cummings CT, Deryckere D, Earp HS, Graham DK. Molecular pathways: MERTK signaling in cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2013;19(19):5275\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1451.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"6398_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/(sici)1097-0142(19990701)86:1<43::aid-cncr8>3.0.co;2-d","volume":"86","author":"A Wimmel","year":"1999","unstructured":"Wimmel A, Rohner I, Ramaswamy A, et al. Synthesis and secretion of the anticoagulant protein S and coexpression of the Tyro3 receptor in human lung carcinoma cells. Cancer. 1999;86(1):43\u20139. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19990701)86:1%3c43::aid-cncr8%3e3.0.co;2-d.","journal-title":"Cancer"},{"issue":"2","key":"6398_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang S, Qiu Z, Hou Y, et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 2021;31(2):126\u201340. https:\/\/doi.org\/10.1038\/s41422-020-00460-y.","journal-title":"Cell Res"},{"key":"6398_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107893","volume":"227","author":"JP Vago","year":"2021","unstructured":"Vago JP, Amaral FA, van de Loo FAJ. Resolving inflammation by TAM receptor activation. Pharmacol Ther. 2021;227: 107893. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107893.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"6398_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14348\/molcells.2018.0419","volume":"42","author":"CH Lee","year":"2019","unstructured":"Lee CH, Chun T. Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function. Mol Cells. 2019;42(1):1\u20137. https:\/\/doi.org\/10.14348\/molcells.2018.0419.","journal-title":"Mol Cells"},{"issue":"1","key":"6398_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-019-1090-3","volume":"18","author":"C Zhu","year":"2019","unstructured":"Zhu C, Wei Y, Wei X. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. Mol Cancer. 2019;18(1):153. https:\/\/doi.org\/10.1186\/s12943-019-1090-3.","journal-title":"Mol Cancer"},{"issue":"1","key":"6398_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12250-020-00264-9","volume":"36","author":"ZY Wang","year":"2021","unstructured":"Wang ZY, Wang PG, An J. The multifaceted roles of TAM receptors during viral infection. Virol Sin. 2021;36(1):1\u201312. https:\/\/doi.org\/10.1007\/s12250-020-00264-9.","journal-title":"Virol Sin"},{"issue":"1","key":"6398_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12964-019-0461-0","volume":"17","author":"T Burstyn-Cohen","year":"2019","unstructured":"Burstyn-Cohen T, Maimon A. TAM receptors, phosphatidylserine, inflammation, and cancer. Cell Commun Signal CCS. 2019;17(1):156. https:\/\/doi.org\/10.1186\/s12964-019-0461-0.","journal-title":"Cell Commun Signal CCS"},{"key":"6398_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869676","volume":"13","author":"AST Engelsen","year":"2022","unstructured":"Engelsen AST, Lotsberg ML, Abou Khouzam R, et al. Dissecting the Role of AXL in cancer immune escape and resistance to immune checkpoint inhibition. Front Immunol. 2022;13: 869676. https:\/\/doi.org\/10.3389\/fimmu.2022.869676.","journal-title":"Front Immunol"},{"issue":"16","key":"6398_CR27","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1182\/blood-2013-09-528752","volume":"123","author":"JHM van der Meer","year":"2014","unstructured":"van der Meer JHM, van der Poll T, Veer C. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood. 2014;123(16):2460\u20139. https:\/\/doi.org\/10.1182\/blood-2013-09-528752.","journal-title":"Blood."},{"issue":"12","key":"6398_CR28","first-page":"2349","volume":"10","author":"DK Graham","year":"1995","unstructured":"Graham DK, Bowman GW, Dawson TL, Stanford WL, Earp HS, Snodgrass HR. Cloning and developmental expression analysis of the murine c-mer tyrosine kinase. Oncogene. 1995;10(12):2349\u201359.","journal-title":"Oncogene"},{"key":"6398_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","volume":"100","author":"RMA Linger","year":"2008","unstructured":"Linger RMA, Keating AK, Earp HS, Graham DK. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res. 2008;100:35\u201383. https:\/\/doi.org\/10.1016\/S0065-230X(08)00002-X.","journal-title":"Adv Cancer Res"},{"key":"6398_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","volume":"33","author":"CV Rothlin","year":"2015","unstructured":"Rothlin CV, Carrera-Silva EA, Bosurgi L, Ghosh S. TAM receptor signaling in immune homeostasis. Annu Rev Immunol. 2015;33:355\u201391. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112103.","journal-title":"Annu Rev Immunol"},{"key":"6398_CR31","doi-asserted-by":"publisher","unstructured":"Behrens EM, Gadue P, Gong S, Garrett S, Stein PL, Cohen PL. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. Eur J Immunol. 2003;33(8):2160\u20132167. https:\/\/doi.org\/10.1002\/eji.200324076","DOI":"10.1002\/eji.200324076"},{"issue":"5","key":"6398_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/jclinpath-2016-203629","volume":"69","author":"M Brown","year":"2016","unstructured":"Brown M, Black JRM, Sharma R, Stebbing J, Pinato DJ. Gene of the month: Axl. J Clin Pathol. 2016;69(5):391\u20137. https:\/\/doi.org\/10.1136\/jclinpath-2016-203629.","journal-title":"J Clin Pathol"},{"issue":"7","key":"6398_CR33","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141(7):1117\u201334. https:\/\/doi.org\/10.1016\/j.cell.2010.06.011.","journal-title":"Cell"},{"issue":"2","key":"6398_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/84667","volume":"7","author":"A Angelillo-Scherrer","year":"2001","unstructured":"Angelillo-Scherrer A, de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med. 2001;7(2):215\u201321. https:\/\/doi.org\/10.1038\/84667.","journal-title":"Nat Med"},{"issue":"7","key":"6398_CR35","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/emboj.2012.21","volume":"31","author":"GX Ruan","year":"2012","unstructured":"Ruan GX, Kazlauskas A. Axl is essential for VEGF-A-dependent activation of PI3K\/Akt. EMBO J. 2012;31(7):1692\u2013703. https:\/\/doi.org\/10.1038\/emboj.2012.21.","journal-title":"EMBO J"},{"issue":"4","key":"6398_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cytogfr.2006.04.004","volume":"17","author":"S Hafizi","year":"2006","unstructured":"Hafizi S, Dahlb\u00e4ck B. Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev. 2006;17(4):295\u2013304. https:\/\/doi.org\/10.1016\/j.cytogfr.2006.04.004.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"6398_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12964-018-0308-0","volume":"16","author":"J Zhou","year":"2018","unstructured":"Zhou J, Yang A, Wang Y, et al. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation. Cell Commun Signal CCS. 2018;16(1):98. https:\/\/doi.org\/10.1186\/s12964-018-0308-0.","journal-title":"Cell Commun Signal CCS"},{"issue":"8","key":"6398_CR38","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/j.1538-7836.2010.03935.x","volume":"8","author":"JMEM Cosemans","year":"2010","unstructured":"Cosemans JMEM, Van Kruchten R, Olieslagers S, et al. Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost JTH. 2010;8(8):1797\u2013808. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03935.x.","journal-title":"J Thromb Haemost JTH"},{"issue":"4","key":"6398_CR39","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1538-7836.2005.01186.x","volume":"3","author":"WR Gould","year":"2005","unstructured":"Gould WR, Baxi SM, Schroeder R, et al. Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Thromb Haemost JTH. 2005;3(4):733\u201341. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01186.x.","journal-title":"J Thromb Haemost JTH"},{"issue":"8","key":"6398_CR40","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1182\/blood-2007-05-089565","volume":"111","author":"M Tjwa","year":"2008","unstructured":"Tjwa M, Bellido-Martin L, Lin Y, et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood. 2008;111(8):4096\u2013105. https:\/\/doi.org\/10.1182\/blood-2007-05-089565.","journal-title":"Blood"},{"issue":"10","key":"6398_CR41","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1089\/vim.2022.0112","volume":"35","author":"G Baskol","year":"2022","unstructured":"Baskol G, \u00d6zel M, Saracoglu H, et al. New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients. Viral Immunol. 2022;35(10):690\u20139. https:\/\/doi.org\/10.1089\/vim.2022.0112.","journal-title":"Viral Immunol"},{"key":"6398_CR42","doi-asserted-by":"publisher","unstructured":"Korshunov VA. Axl-dependent signalling: a clinical update. Clin Sci Lond Engl 1979. 2012;122(8):361\u2013368. https:\/\/doi.org\/10.1042\/CS20110411","DOI":"10.1042\/CS20110411"},{"issue":"11","key":"6398_CR43","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/2326-6066.CIR-18-0903","volume":"7","author":"S Terry","year":"2019","unstructured":"Terry S, Abdou A, Engelsen AST, et al. AXL targeting overcomes human lung cancer cell resistance to NK- and CTL-mediated cytotoxicity. Cancer Immunol Res. 2019;7(11):1789\u2013802. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0903.","journal-title":"Cancer Immunol Res"},{"issue":"6834","key":"6398_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35075603","volume":"411","author":"RS Scott","year":"2001","unstructured":"Scott RS, McMahon EJ, Pop SM, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001;411(6834):207\u201311. https:\/\/doi.org\/10.1038\/35075603.","journal-title":"Nature"},{"issue":"2","key":"6398_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1165\/rcmb.2004-0108OC","volume":"32","author":"JH Jennings","year":"2005","unstructured":"Jennings JH, Linderman DJ, Hu B, Sonstein J, Curtis JL. Monocytes recruited to the lungs of mice during immune inflammation ingest apoptotic cells poorly. Am J Respir Cell Mol Biol. 2005;32(2):108\u201317. https:\/\/doi.org\/10.1165\/rcmb.2004-0108OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"6398_CR46","doi-asserted-by":"publisher","unstructured":"Tibrewal N, Wu Y, D\u2019mello V, et al. Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-kappaB transcriptional activation. J Biol Chem. 2008;283(6):3618\u20133627. https:\/\/doi.org\/10.1074\/jbc.M706906200","DOI":"10.1074\/jbc.M706906200"},{"key":"6398_CR47","doi-asserted-by":"publisher","unstructured":"Filardy AA, Pires DR, Nunes MP, et al. Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages. J Immunol Baltim Md 1950. 2010;185(4):2044\u20132050. https:\/\/doi.org\/10.4049\/jimmunol.1000017","DOI":"10.4049\/jimmunol.1000017"},{"issue":"2","key":"6398_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1620\/tjem.168.169","volume":"168","author":"T Curran","year":"1992","unstructured":"Curran T. Fos and Jun: oncogenic transcription factors. Tohoku J Exp Med. 1992;168(2):169\u201374. https:\/\/doi.org\/10.1620\/tjem.168.169.","journal-title":"Tohoku J Exp Med"},{"key":"6398_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107577","volume":"213","author":"JM Huelse","year":"2020","unstructured":"Huelse JM, Fridlyand DM, Earp S, DeRyckere D, Graham DK. MERTK in cancer therapy: targeting the receptor tyrosine kinase in tumor cells and the immune system. Pharmacol Ther. 2020;213: 107577. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107577.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"6398_CR50","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/2326-6066.CIR-18-0841","volume":"7","author":"MJW Peeters","year":"2019","unstructured":"Peeters MJW, Dulkeviciute D, Draghi A, et al. MERTK acts as a costimulatory receptor on human CD8+ T cells. Cancer Immunol Res. 2019;7(9):1472\u201384. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0841.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"6398_CR51","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.immuni.2013.06.010","volume":"39","author":"EA Carrera Silva","year":"2013","unstructured":"Carrera Silva EA, Chan PY, Joannas L, et al. T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response. Immunity. 2013;39(1):160\u201370. https:\/\/doi.org\/10.1016\/j.immuni.2013.06.010.","journal-title":"Immunity"},{"issue":"2","key":"6398_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1172\/JCI30375","volume":"118","author":"A Angelillo-Scherrer","year":"2008","unstructured":"Angelillo-Scherrer A, Burnier L, Lambrechts D, et al. Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest. 2008;118(2):583\u201396. https:\/\/doi.org\/10.1172\/JCI30375.","journal-title":"J Clin Invest"},{"issue":"2","key":"6398_CR53","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/jth.13875","volume":"16","author":"BR Branchford","year":"2018","unstructured":"Branchford BR, Stalker TJ, Law L, et al. The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost JTH. 2018;16(2):352\u201363. https:\/\/doi.org\/10.1111\/jth.13875.","journal-title":"J Thromb Haemost JTH"},{"issue":"6","key":"6398_CR54","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1161\/01.ATV.0000130662.30537.08","volume":"24","author":"C Chen","year":"2004","unstructured":"Chen C, Li Q, Darrow AL, et al. Mer receptor tyrosine kinase signaling participates in platelet function. Arterioscler Thromb Vasc Biol. 2004;24(6):1118\u201323. https:\/\/doi.org\/10.1161\/01.ATV.0000130662.30537.08.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"6398_CR55","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025.","journal-title":"Cell"},{"issue":"29","key":"6398_CR56","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1038\/onc.2012.355","volume":"32","author":"RMA Linger","year":"2013","unstructured":"Linger RMA, Cohen RA, Cummings CT, et al. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene. 2013;32(29):3420\u201331. https:\/\/doi.org\/10.1038\/onc.2012.355.","journal-title":"Oncogene"},{"issue":"6","key":"6398_CR57","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/s0092-8674(88)91065-3","volume":"54","author":"C Schneider","year":"1988","unstructured":"Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54(6):787\u201393. https:\/\/doi.org\/10.1016\/s0092-8674(88)91065-3.","journal-title":"Cell"},{"key":"6398_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.thromres.2024.05.002","volume":"238","author":"F Li","year":"2024","unstructured":"Li F, Xu L, Li C, Hu F, Su Y. Immunological role of Gas6\/TAM signaling in hemostasis and thrombosis. Thromb Res. 2024;238:161\u201371. https:\/\/doi.org\/10.1016\/j.thromres.2024.05.002.","journal-title":"Thromb Res"},{"issue":"4","key":"6398_CR59","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1182\/blood-2012-05-433730","volume":"121","author":"RS Robins","year":"2013","unstructured":"Robins RS, Lemari\u00e9 CA, Laurance S, Aghourian MN, Wu J, Blostein MD. Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice. Blood. 2013;121(4):692\u20139. https:\/\/doi.org\/10.1182\/blood-2012-05-433730.","journal-title":"Blood"},{"issue":"2","key":"6398_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1535370219828195","volume":"244","author":"PL Hsu","year":"2019","unstructured":"Hsu PL, Jou J, Tsai SJ. TYRO3: A potential therapeutic target in cancer. Exp Biol Med Maywood NJ. 2019;244(2):83\u201399. https:\/\/doi.org\/10.1177\/1535370219828195.","journal-title":"Exp Biol Med Maywood NJ"},{"issue":"2","key":"6398_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/JCI22079","volume":"115","author":"A Angelillo-Scherrer","year":"2005","unstructured":"Angelillo-Scherrer A, Burnier L, Flores N, et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest. 2005;115(2):237\u201346. https:\/\/doi.org\/10.1172\/JCI22079.","journal-title":"J Clin Invest"},{"issue":"5","key":"6398_CR62","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0896-6273(91)90167-x","volume":"6","author":"C Lai","year":"1991","unstructured":"Lai C, Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron. 1991;6(5):691\u2013704. https:\/\/doi.org\/10.1016\/0896-6273(91)90167-x.","journal-title":"Neuron"},{"key":"6398_CR63","doi-asserted-by":"publisher","unstructured":"Liu Y, Zeng G. Cancer and innate immune system interactions: translational potentials for cancer immunotherapy. J Immunother Hagerstown Md. 2012;35(4): 299\u2013308. https:\/\/doi.org\/10.1097\/CJI.0b013e3182518e83","DOI":"10.1097\/CJI.0b013e3182518e83"},{"issue":"4","key":"6398_CR64","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0092-8674(95)90520-0","volume":"80","author":"TN Stitt","year":"1995","unstructured":"Stitt TN, Conn G, Gore M, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3\/Axl family of receptor tyrosine kinases. Cell. 1995;80(4):661\u201370. https:\/\/doi.org\/10.1016\/0092-8674(95)90520-0.","journal-title":"Cell"},{"issue":"5","key":"6398_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nri2303","volume":"8","author":"G Lemke","year":"2008","unstructured":"Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008;8(5):327\u201336. https:\/\/doi.org\/10.1038\/nri2303.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"6398_CR66","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1158\/0008-5472.CAN-16-2675","volume":"77","author":"M Vouri","year":"2017","unstructured":"Vouri M, Hafizi S. TAM receptor tyrosine kinases in cancer drug resistance. Cancer Res. 2017;77(11):2775\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2675.","journal-title":"Cancer Res"},{"issue":"2","key":"6398_CR67","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1182\/blood.V95.2.633","volume":"95","author":"Z Lan","year":"2000","unstructured":"Lan Z, Wu H, Li W, et al. Transforming activity of receptor tyrosine kinase tyro3 is mediated, at least in part, by the PI3 kinase-signaling pathway. Blood. 2000;95(2):633\u20138.","journal-title":"Blood"},{"issue":"11","key":"6398_CR68","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.2967\/jnumed.115.157438","volume":"57","author":"PM Scherer","year":"2016","unstructured":"Scherer PM, Chen DL. Imaging pulmonary inflammation. J Nucl Med Off Publ Soc Nucl Med. 2016;57(11):1764\u201370. https:\/\/doi.org\/10.2967\/jnumed.115.157438.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"6","key":"6398_CR69","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/15412555.2016.1191456","volume":"13","author":"SS Gautam","year":"2016","unstructured":"Gautam SS, O\u2019Toole RF. Convergence in the epidemiology and pathogenesis of COPD and pneumonia. COPD. 2016;13(6):790\u20138. https:\/\/doi.org\/10.1080\/15412555.2016.1191456.","journal-title":"COPD"},{"issue":"3","key":"6398_CR70","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1152\/physrev.00032.2017","volume":"98","author":"LJ Quinton","year":"2018","unstructured":"Quinton LJ, Walkey AJ, Mizgerd JP. Integrative physiology of pneumonia. Physiol Rev. 2018;98(3):1417\u201364. https:\/\/doi.org\/10.1152\/physrev.00032.2017.","journal-title":"Physiol Rev"},{"issue":"1","key":"6398_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ni.3056","volume":"16","author":"C Chiu","year":"2015","unstructured":"Chiu C, Openshaw PJ. Antiviral B cell and T cell immunity in the lungs. Nat Immunol. 2015;16(1):18\u201326. https:\/\/doi.org\/10.1038\/ni.3056.","journal-title":"Nat Immunol"},{"issue":"9","key":"6398_CR72","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1164\/rccm.201206-1063PP","volume":"186","author":"JP Mizgerd","year":"2012","unstructured":"Mizgerd JP. Respiratory infection and the impact of pulmonary immunity on lung health and disease. Am J Respir Crit Care Med. 2012;186(9):824\u20139. https:\/\/doi.org\/10.1164\/rccm.201206-1063PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"6398_CR73","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-physiol-021014-071937","volume":"77","author":"LJ Quinton","year":"2015","unstructured":"Quinton LJ, Mizgerd JP. Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling. Annu Rev Physiol. 2015;77:407\u201330. https:\/\/doi.org\/10.1146\/annurev-physiol-021014-071937.","journal-title":"Annu Rev Physiol"},{"issue":"7","key":"6398_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219788","volume":"14","author":"CK Peng","year":"2019","unstructured":"Peng CK, Wu CP, Lin JY, et al. Gas6\/Axl signaling attenuates alveolar inflammation in ischemia-reperfusion-induced acute lung injury by up-regulating SOCS3-mediated pathway. PLoS ONE. 2019;14(7): e0219788. https:\/\/doi.org\/10.1371\/journal.pone.0219788.","journal-title":"PLoS ONE"},{"key":"6398_CR75","doi-asserted-by":"publisher","first-page":"1380628","DOI":"10.3389\/fimmu.2024.1380628","volume":"15","author":"K Guimar\u00e3es-Pinto","year":"2024","unstructured":"Guimar\u00e3es-Pinto K, Leandro M, Corr\u00eaa A, et al. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl. Front Immunol. 2024;15:1380628. https:\/\/doi.org\/10.3389\/fimmu.2024.1380628.","journal-title":"Front Immunol"},{"issue":"1","key":"6398_CR76","doi-asserted-by":"publisher","first-page":"L69","DOI":"10.1152\/ajplung.00058.2017","volume":"314","author":"MP Mohning","year":"2018","unstructured":"Mohning MP, Thomas SM, Barthel L, et al. Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK. Am J Physiol Lung Cell Mol Physiol. 2018;314(1):L69\u201382. https:\/\/doi.org\/10.1152\/ajplung.00058.2017.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"6398_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225051","volume":"14","author":"Y Li","year":"2019","unstructured":"Li Y, Wittchen ES, Monaghan-Benson E, et al. The role of endothelial MERTK during the inflammatory response in lungs. PLoS ONE. 2019;14(12): e0225051. https:\/\/doi.org\/10.1371\/journal.pone.0225051.","journal-title":"PLoS ONE"},{"issue":"Pt A","key":"6398_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112832","volume":"142","author":"F Li","year":"2024","unstructured":"Li F, Bai Y, Guan Z, et al. Dexmedetomidine attenuates sepsis-associated acute lung injury by regulating macrophage efferocytosis through the ROS\/ADAM10\/AXL pathway. Int Immunopharmacol. 2024;142(Pt A): 112832. https:\/\/doi.org\/10.1016\/j.intimp.2024.112832.","journal-title":"Int Immunopharmacol"},{"key":"6398_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.toxlet.2018.04.009","volume":"292","author":"C Zhang","year":"2018","unstructured":"Zhang C, Zhao H, Li BL, et al. CpG-oligodeoxynucleotides may be effective for preventing ionizing radiation induced pulmonary fibrosis. Toxicol Lett. 2018;292:181\u20139. https:\/\/doi.org\/10.1016\/j.toxlet.2018.04.009.","journal-title":"Toxicol Lett"},{"key":"6398_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.114100","volume":"245","author":"N Li","year":"2022","unstructured":"Li N, Lin Z, Zhou Q, et al. Metformin alleviates crystalline silica-induced pulmonary fibrosis by remodeling endothelial cells to mesenchymal transition via autophagy signaling. Ecotoxicol Environ Saf. 2022;245: 114100. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.114100.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"8","key":"6398_CR81","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1172\/JCI60323","volume":"122","author":"PW Noble","year":"2012","unstructured":"Noble PW, Barkauskas CE, Jiang D. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest. 2012;122(8):2756\u201362. https:\/\/doi.org\/10.1172\/JCI60323.","journal-title":"J Clin Invest"},{"issue":"3","key":"6398_CR82","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1172\/JCI31487","volume":"117","author":"TA Wynn","year":"2007","unstructured":"Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117(3):524\u20139. https:\/\/doi.org\/10.1172\/JCI31487.","journal-title":"J Clin Invest"},{"key":"6398_CR83","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","volume":"147","author":"P Heukels","year":"2019","unstructured":"Heukels P, Moor CC, von der Th\u00fcsen JH, Wijsenbeek MS, Kool M. Inflammation and immunity in IPF pathogenesis and treatment. Respir Med. 2019;147:79\u201391. https:\/\/doi.org\/10.1016\/j.rmed.2018.12.015.","journal-title":"Respir Med"},{"issue":"16","key":"6398_CR84","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364(16):1503\u201312. https:\/\/doi.org\/10.1056\/NEJMoa1013660.","journal-title":"N Engl J Med"},{"key":"6398_CR85","doi-asserted-by":"publisher","unstructured":"Cj S, H S, C F, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax. 2013;68: 5. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-201786","DOI":"10.1136\/thoraxjnl-2012-201786"},{"issue":"6","key":"6398_CR86","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2609","volume":"45","author":"TE Fingerlin","year":"2013","unstructured":"Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013;45(6):613\u201320. https:\/\/doi.org\/10.1038\/ng.2609.","journal-title":"Nat Genet"},{"issue":"1","key":"6398_CR87","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1164\/rccm.201610-2088OC","volume":"196","author":"S Petrovski","year":"2017","unstructured":"Petrovski S, Todd JL, Durheim MT, et al. An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis. Am J Respir Crit Care Med. 2017;196(1):82\u201393. https:\/\/doi.org\/10.1164\/rccm.201610-2088OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"6398_CR88","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1513\/AnnalsATS.201404-145OC","volume":"11","author":"JP Hutchinson","year":"2014","unstructured":"Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc. 2014;11(8):1176\u201385. https:\/\/doi.org\/10.1513\/AnnalsATS.201404-145OC.","journal-title":"Ann Am Thorac Soc"},{"key":"6398_CR89","doi-asserted-by":"publisher","unstructured":"Esposito DB, Lanes S, Donneyong M, et al. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation. Am J Respir Crit Care Med. 2015;192(10):1200\u20131207. https:\/\/doi.org\/10.1164\/rccm.201504-0818OC","DOI":"10.1164\/rccm.201504-0818OC"},{"issue":"6","key":"6398_CR90","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1165\/rcmb.2020-0303OC","volume":"64","author":"DC Yang","year":"2021","unstructured":"Yang DC, Gu S, Li JM, et al. Targeting the AXL receptor in combating smoking-related pulmonary fibrosis. Am J Respir Cell Mol Biol. 2021;64(6):734\u201346. https:\/\/doi.org\/10.1165\/rcmb.2020-0303OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"6398_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.134786","volume":"474","author":"Q Liu","year":"2024","unstructured":"Liu Q, Niu Y, Pei Z, et al. Gas6-Axl signal promotes indoor VOCs exposure-induced pulmonary fibrosis via pulmonary microvascular endothelial cells-fibroblasts cross-talk. J Hazard Mater. 2024;474: 134786. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.134786.","journal-title":"J Hazard Mater"},{"issue":"8","key":"6398_CR92","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3390\/microorganisms11082038","volume":"11","author":"D Apostolo","year":"2023","unstructured":"Apostolo D, Ferreira LL, Di Tizio A, Ruaro B, Patrucco F, Bellan M. A review: the potential involvement of growth arrest-specific 6 and its receptors in the pathogenesis of lung damage and in coronavirus disease 2019. Microorganisms. 2023;11(8):2038. https:\/\/doi.org\/10.3390\/microorganisms11082038.","journal-title":"Microorganisms"},{"issue":"159","key":"6398_CR93","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0085-2020","volume":"30","author":"CHM van Moorsel","year":"2021","unstructured":"van Moorsel CHM, van der Vis JJ, Grutters JC. Genetic disorders of the surfactant system: focus on adult disease. Eur Respir Rev Off J Eur Respir Soc. 2021;30(159): 200085. https:\/\/doi.org\/10.1183\/16000617.0085-2020.","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"issue":"7","key":"6398_CR94","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/dna.2024.0099","volume":"43","author":"Z Pan","year":"2024","unstructured":"Pan Z, Eslam M. MERTK and fibrosis: a new target for therapy. DNA Cell Biol. 2024;43(7):311\u20134. https:\/\/doi.org\/10.1089\/dna.2024.0099.","journal-title":"DNA Cell Biol"},{"key":"6398_CR95","doi-asserted-by":"publisher","unstructured":"Pan Z, El Sharkway R, Bayoumi A, et al. Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease. Sci Transl Med. 2024;16(741):eadj0133. https:\/\/doi.org\/10.1126\/scitranslmed.adj0133","DOI":"10.1126\/scitranslmed.adj0133"},{"key":"6398_CR96","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.matbio.2018.03.021","volume":"71\u201372","author":"JC Hewlett","year":"2018","unstructured":"Hewlett JC, Kropski JA, Blackwell TS. Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets. Matrix Biol J Int Soc Matrix Biol. 2018;71\u201372:112\u201327. https:\/\/doi.org\/10.1016\/j.matbio.2018.03.021.","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"issue":"3","key":"6398_CR97","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1165\/rcmb.2020-0156ED","volume":"63","author":"R Guzy","year":"2020","unstructured":"Guzy R. Fibroblast growth factor inhibitors in lung fibrosis: friends or foes? Am J Respir Cell Mol Biol. 2020;63(3):273\u20134. https:\/\/doi.org\/10.1165\/rcmb.2020-0156ED.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"6398_CR98","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1165\/rcmb.2013-0455OC","volume":"51","author":"Y Aono","year":"2014","unstructured":"Aono Y, Kishi M, Yokota Y, et al. Role of platelet-derived growth factor\/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2014;51(6):793\u2013801. https:\/\/doi.org\/10.1165\/rcmb.2013-0455OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"6398_CR99","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1183\/09031936.01.00074101","volume":"17","author":"LH Pan","year":"2001","unstructured":"Pan LH, Yamauchi K, Uzuki M, et al. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J. 2001;17(6):1220\u20137. https:\/\/doi.org\/10.1183\/09031936.01.00074101.","journal-title":"Eur Respir J"},{"issue":"26","key":"6398_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401394","volume":"11","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Jiang X, Yi L, et al. Mitochondria energy metabolism depression as novel adjuvant to sensitize radiotherapy and inhibit radiation induced-pulmonary fibrosis. Adv Sci Weinh Baden-Wurtt Ger. 2024;11(26): e2401394. https:\/\/doi.org\/10.1002\/advs.202401394.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"issue":"4","key":"6398_CR101","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1538-7836.2010.03752.x","volume":"8","author":"C Ekman","year":"2010","unstructured":"Ekman C, Stenhoff J, Dahlb\u00e4ck B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost JTH. 2010;8(4):838\u201344. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03752.x.","journal-title":"J Thromb Haemost JTH"},{"issue":"9","key":"6398_CR102","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/labinvest.2017.52","volume":"97","author":"N Fujino","year":"2017","unstructured":"Fujino N, Kubo H, Maciewicz RA. Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotype. Lab Investig J Tech Methods Pathol. 2017;97(9):1047\u201362. https:\/\/doi.org\/10.1038\/labinvest.2017.52.","journal-title":"Lab Investig J Tech Methods Pathol"},{"issue":"1","key":"6398_CR103","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10565-024-09858-5","volume":"40","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Kim M, Kim HS, Kang JL. Administration of Gas6 attenuates lung fibrosis via inhibition of the epithelial-mesenchymal transition and fibroblast activation. Cell Biol Toxicol. 2024;40(1):20. https:\/\/doi.org\/10.1007\/s10565-024-09858-5.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"6398_CR104","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12931-023-02424-3","volume":"24","author":"Y She","year":"2023","unstructured":"She Y, Xu X, Yu Q, Yang X, He J, Tang XX. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis. Respir Res. 2023;24(1):118. https:\/\/doi.org\/10.1186\/s12931-023-02424-3.","journal-title":"Respir Res"},{"issue":"1","key":"6398_CR105","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70321","volume":"29","author":"X Zhao","year":"2025","unstructured":"Zhao X, Li Y, Yang S, et al. orderly regulation of macrophages and fibroblasts by Axl in bleomycin-induced pulmonary fibrosis in mice. J Cell Mol Med. 2025;29(1): e70321. https:\/\/doi.org\/10.1111\/jcmm.70321.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"6398_CR106","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","volume":"103","author":"F Nasim","year":"2019","unstructured":"Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463\u201373. https:\/\/doi.org\/10.1016\/j.mcna.2018.12.006.","journal-title":"Med Clin North Am"},{"issue":"1","key":"6398_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1\u201324. https:\/\/doi.org\/10.1016\/j.ccm.2019.10.001.","journal-title":"Clin Chest Med"},{"issue":"9","key":"6398_CR108","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1111\/cas.14547","volume":"111","author":"C Zhong","year":"2020","unstructured":"Zhong C, Chen C, Yao F, Fang W. ZNF251 promotes the progression of lung cancer by activating ERK signaling. Cancer Sci. 2020;111(9):3236\u201344. https:\/\/doi.org\/10.1111\/cas.14547.","journal-title":"Cancer Sci"},{"issue":"4","key":"6398_CR109","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3390\/cells9040861","volume":"9","author":"H Kim","year":"2020","unstructured":"Kim H, Lee S, Shin E, et al. The emerging roles of exosomes as EMT regulators in cancer. Cells. 2020;9(4):861. https:\/\/doi.org\/10.3390\/cells9040861.","journal-title":"Cells"},{"issue":"6","key":"6398_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12828","volume":"53","author":"C Hu","year":"2020","unstructured":"Hu C, Meiners S, Lukas C, Stathopoulos GT, Chen J. Role of exosomal microRNAs in lung cancer biology and clinical applications. Cell Prolif. 2020;53(6): e12828. https:\/\/doi.org\/10.1111\/cpr.12828.","journal-title":"Cell Prolif"},{"issue":"1","key":"6398_CR111","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng Z, Li Y, Pan Y, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9(1):5395. https:\/\/doi.org\/10.1038\/s41467-018-07810-w.","journal-title":"Nat Commun"},{"issue":"4","key":"6398_CR112","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3892\/or.2020.7496","volume":"43","author":"D Zhang","year":"2020","unstructured":"Zhang D, Li D, Shen L, et al. Exosomes derived from Piwil2-induced cancer stem cells transform fibroblasts into cancer-associated fibroblasts. Oncol Rep. 2020;43(4):1125\u201332. https:\/\/doi.org\/10.3892\/or.2020.7496.","journal-title":"Oncol Rep"},{"key":"6398_CR113","doi-asserted-by":"publisher","first-page":"6272498","DOI":"10.1155\/2020\/6272498","volume":"2020","author":"W Olejarz","year":"2020","unstructured":"Olejarz W, Dominiak A, \u017bo\u0142nierzak A, Kubiak-Tomaszewska G, Lorenc T. Tumor-derived exosomes in immunosuppression and immunotherapy. J Immunol Res. 2020;2020:6272498. https:\/\/doi.org\/10.1155\/2020\/6272498.","journal-title":"J Immunol Res"},{"key":"6398_CR114","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2017.01.004","volume":"67","author":"RJ Lobb","year":"2017","unstructured":"Lobb RJ, Lima LG, M\u00f6ller A. Exosomes: Key mediators of metastasis and pre-metastatic niche formation. Semin Cell Dev Biol. 2017;67:3\u201310. https:\/\/doi.org\/10.1016\/j.semcdb.2017.01.004.","journal-title":"Semin Cell Dev Biol"},{"issue":"38","key":"6398_CR115","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1038\/onc.2010.268","volume":"29","author":"X Ye","year":"2010","unstructured":"Ye X, Li Y, Stawicki S, et al. An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies. Oncogene. 2010;29(38):5254\u201364. https:\/\/doi.org\/10.1038\/onc.2010.268.","journal-title":"Oncogene"},{"issue":"39","key":"6398_CR116","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1038\/onc.2009.212","volume":"28","author":"Y Li","year":"2009","unstructured":"Li Y, Ye X, Tan C, et al. Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene. 2009;28(39):3442\u201355. https:\/\/doi.org\/10.1038\/onc.2009.212.","journal-title":"Oncogene"},{"key":"6398_CR117","doi-asserted-by":"publisher","unstructured":"Wimmel A, Glitz D, Kraus A, Roeder J, Schuermann M. Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. Eur J Cancer Oxf Engl. 2001;37(17):2264\u20132274. https:\/\/doi.org\/10.1016\/s0959-8049(01)00271-4","DOI":"10.1016\/s0959-8049(01)00271-4"},{"issue":"5","key":"6398_CR118","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/mi.2014.129","volume":"8","author":"T Fujimori","year":"2015","unstructured":"Fujimori T, Grabiec AM, Kaur M, et al. The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung. Mucosal Immunol. 2015;8(5):1021\u201330. https:\/\/doi.org\/10.1038\/mi.2014.129.","journal-title":"Mucosal Immunol"},{"issue":"8","key":"6398_CR119","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jtho.2016.04.015","volume":"11","author":"PA Levin","year":"2016","unstructured":"Levin PA, Brekken RA, Byers LA, Heymach JV, Gerber DE. Axl receptor axis: a new therapeutic target in lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2016;11(8):1357\u201362. https:\/\/doi.org\/10.1016\/j.jtho.2016.04.015.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"43","key":"6398_CR120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404709121","volume":"121","author":"J Zhu","year":"2024","unstructured":"Zhu J, Du W, Zeng Y, et al. CD73 promotes non\u2013small cell lung cancer metastasis by regulating Axl signaling independent of GAS6. Proc Natl Acad Sci. 2024;121(43): e2404709121. https:\/\/doi.org\/10.1073\/pnas.2404709121.","journal-title":"Proc Natl Acad Sci"},{"issue":"20","key":"6398_CR121","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-14-1009","volume":"74","author":"C Wilson","year":"2014","unstructured":"Wilson C, Ye X, Pham T, et al. AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs. Cancer Res. 2014;74(20):5878\u201390. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1009.","journal-title":"Cancer Res"},{"issue":"1","key":"6398_CR122","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1541-7786.MCR-16-0157","volume":"15","author":"K Balaji","year":"2017","unstructured":"Balaji K, Vijayaraghavan S, Diao L, et al. AXL Inhibition Suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancers. Mol Cancer Res MCR. 2017;15(1):45\u201358. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0157.","journal-title":"Mol Cancer Res MCR"},{"issue":"3","key":"6398_CR123","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.0909333107","volume":"107","author":"C Gjerdrum","year":"2010","unstructured":"Gjerdrum C, Tiron C, H\u00f8iby T, et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci U S A. 2010;107(3):1124\u20139. https:\/\/doi.org\/10.1073\/pnas.0909333107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6398_CR124","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442\u201354. https:\/\/doi.org\/10.1038\/nrc822.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"6398_CR125","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/JTO.0b013e318216ee52","volume":"6","author":"K Suda","year":"2011","unstructured":"Suda K, Tomizawa K, Fujii M, et al. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2011;6(7):1152\u201361. https:\/\/doi.org\/10.1097\/JTO.0b013e318216ee52.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"6398_CR126","doi-asserted-by":"publisher","unstructured":"Sequist LV, Waltman BA, Dias-Santagata D, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011;3(75):75ra26. https:\/\/doi.org\/10.1126\/scitranslmed.3002003","DOI":"10.1126\/scitranslmed.3002003"},{"issue":"12","key":"6398_CR127","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1002\/jcp.25797","volume":"232","author":"T Chen","year":"2017","unstructured":"Chen T, You Y, Jiang H, Wang ZZ. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017;232(12):3261\u201372. https:\/\/doi.org\/10.1002\/jcp.25797.","journal-title":"J Cell Physiol"},{"issue":"10","key":"6398_CR128","first-page":"6653","volume":"7","author":"F Wu","year":"2014","unstructured":"Wu F, Li J, Jang C, Wang J, Xiong J. The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma. Int J Clin Exp Pathol. 2014;7(10):6653\u201361.","journal-title":"Int J Clin Exp Pathol"},{"issue":"15","key":"6398_CR129","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.7150\/ijbs.100525","volume":"20","author":"H Zhao","year":"2024","unstructured":"Zhao H, Sun Y, Feng H, et al. PFKP silencing suppresses tumor growth via the AXL-MET axis. Int J Biol Sci. 2024;20(15):6056\u201372. https:\/\/doi.org\/10.7150\/ijbs.100525.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"6398_CR130","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1038\/s41598-020-59281-z","volume":"10","author":"K Namiki","year":"2020","unstructured":"Namiki K, Wongsirisin P, Yokoyama S, et al. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells. Sci Rep. 2020;10(1):2444. https:\/\/doi.org\/10.1038\/s41598-020-59281-z.","journal-title":"Sci Rep"},{"issue":"1","key":"6398_CR131","doi-asserted-by":"publisher","first-page":"17770","DOI":"10.1038\/s41598-017-18120-4","volume":"7","author":"K Iida","year":"2017","unstructured":"Iida K, Sakai R, Yokoyama S, et al. Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL. Sci Rep. 2017;7(1):17770. https:\/\/doi.org\/10.1038\/s41598-017-18120-4.","journal-title":"Sci Rep"},{"issue":"6","key":"6398_CR132","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41401-022-01047-6","volume":"44","author":"JP Pei","year":"2023","unstructured":"Pei JP, Wang Y, Ma LP, et al. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage. Acta Pharmacol Sin. 2023;44(6):1290\u2013303. https:\/\/doi.org\/10.1038\/s41401-022-01047-6.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"6398_CR133","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ng.2330","volume":"44","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lee JC, Lin L, et al. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet. 2012;44(8):852\u201360. https:\/\/doi.org\/10.1038\/ng.2330.","journal-title":"Nat Genet"},{"issue":"1","key":"6398_CR134","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41467-018-08074-0","volume":"10","author":"H Taniguchi","year":"2019","unstructured":"Taniguchi H, Yamada T, Wang R, et al. AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells. Nat Commun. 2019;10(1):259. https:\/\/doi.org\/10.1038\/s41467-018-08074-0.","journal-title":"Nat Commun"},{"issue":"3","key":"6398_CR135","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3892\/ol.2015.3457","volume":"10","author":"XH Qu","year":"2015","unstructured":"Qu XH, Liu JL, Zhong XW, Li XI, Zhang QG. Insights into the roles of hnRNP A2\/B1 and AXL in non-small cell lung cancer. Oncol Lett. 2015;10(3):1677\u201385. https:\/\/doi.org\/10.3892\/ol.2015.3457.","journal-title":"Oncol Lett"},{"issue":"12","key":"6398_CR136","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.humpath.2015.08.014","volume":"46","author":"Z Wu","year":"2015","unstructured":"Wu Z, Bai F, Fan L, et al. Coexpression of receptor tyrosine kinase AXL and EGFR in human primary lung adenocarcinomas. Hum Pathol. 2015;46(12):1935\u201344. https:\/\/doi.org\/10.1016\/j.humpath.2015.08.014.","journal-title":"Hum Pathol"},{"key":"6398_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116475","volume":"272","author":"Z Liu","year":"2024","unstructured":"Liu Z, Chen L, Zhang J, et al. Recent discovery and development of AXL inhibitors as antitumor agents. Eur J Med Chem. 2024;272: 116475. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116475.","journal-title":"Eur J Med Chem"},{"key":"6398_CR138","unstructured":"Rayford A. AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy. Front Immunol."},{"issue":"9","key":"6398_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101703","volume":"5","author":"A Simoni-Nieves","year":"2024","unstructured":"Simoni-Nieves A, Lindzen M, Giri S, et al. A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib. Cell Rep Med. 2024;5(9): 101703. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101703.","journal-title":"Cell Rep Med"},{"issue":"6","key":"6398_CR140","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41401-024-01237-4","volume":"45","author":"R Han","year":"2024","unstructured":"Han R, Lu CH, Hu C, et al. Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer. Acta Pharmacol Sin. 2024;45(6):1264\u201375. https:\/\/doi.org\/10.1038\/s41401-024-01237-4.","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"6398_CR141","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1111\/cas.16292","volume":"115","author":"Y Matsui","year":"2024","unstructured":"Matsui Y, Yamada T, Katayama Y, et al. Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance in EGFR-mutant lung cancer cells. Cancer Sci. 2024;115(10):3333\u201345. https:\/\/doi.org\/10.1111\/cas.16292.","journal-title":"Cancer Sci"},{"issue":"3","key":"6398_CR142","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/ijms25031374","volume":"25","author":"HN Huang","year":"2024","unstructured":"Huang HN, Hung PF, Chen YP, Lee CH. Leucine Zipper Downregulated in Cancer-1 Interacts with Clathrin Adaptors to Control Epidermal Growth Factor Receptor (EGFR) Internalization and Gefitinib Response in EGFR-Mutated Non-Small Cell Lung Cancer. Int J Mol Sci. 2024;25(3):1374. https:\/\/doi.org\/10.3390\/ijms25031374.","journal-title":"Int J Mol Sci"},{"key":"6398_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107468","volume":"188","author":"S Zhao","year":"2024","unstructured":"Zhao S, Ma Y, Liu L, et al. Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations: A phase 1b clinical trial and biomarker analysis. Lung Cancer Amst Neth. 2024;188: 107468. https:\/\/doi.org\/10.1016\/j.lungcan.2024.107468.","journal-title":"Lung Cancer Amst Neth"},{"key":"6398_CR144","doi-asserted-by":"publisher","unstructured":"Huang S, Zhang J, Wu X, et al. RP11\u2013874\u00a0J12.4 promotes erlotinib resistance in non-small cell lung cancer via increasing AXL expression. Life Sci. 2024;351:122849. https:\/\/doi.org\/10.1016\/j.lfs.2024.122849","DOI":"10.1016\/j.lfs.2024.122849"},{"key":"6398_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217124","volume":"598","author":"R Nakamura","year":"2024","unstructured":"Nakamura R, Yamada T, Tokuda S, et al. Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancer. Cancer Lett. 2024;598: 217124. https:\/\/doi.org\/10.1016\/j.canlet.2024.217124.","journal-title":"Cancer Lett"},{"key":"6398_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105356","volume":"108","author":"TTT Tran","year":"2024","unstructured":"Tran TTT, Phung CD, Yeo BZJ, et al. Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer. EBioMedicine. 2024;108: 105356. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105356.","journal-title":"EBioMedicine"},{"key":"6398_CR147","doi-asserted-by":"publisher","first-page":"1447678","DOI":"10.3389\/fonc.2024.1447678","volume":"14","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Gu Z, Yu X, Cheng T, Liu B. Research progress on the role of bypass activation mechanisms in resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Front Oncol. 2024;14:1447678. https:\/\/doi.org\/10.3389\/fonc.2024.1447678.","journal-title":"Front Oncol"},{"issue":"10","key":"6398_CR148","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3324\/haematol.2009.007328","volume":"94","author":"E Lierman","year":"2009","unstructured":"Lierman E, Van Miegroet H, Beullens E, Cools J. Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen. Haematologica. 2009;94(10):1440\u20134. https:\/\/doi.org\/10.3324\/haematol.2009.007328.","journal-title":"Haematologica"},{"issue":"2","key":"6398_CR149","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ph14020130","volume":"14","author":"CJ Chen","year":"2021","unstructured":"Chen CJ, Liu YP. MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. Pharm Basel Switz. 2021;14(2):130. https:\/\/doi.org\/10.3390\/ph14020130.","journal-title":"Pharm Basel Switz"},{"key":"6398_CR150","doi-asserted-by":"publisher","unstructured":"Uehara H, Shacter E. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic cells. J Immunol Baltim Md 1950. 2008;180(4):2522\u20132530. https:\/\/doi.org\/10.4049\/jimmunol.180.4.2522","DOI":"10.4049\/jimmunol.180.4.2522"},{"issue":"8","key":"6398_CR151","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1128\/mcb.13.8.4976-4985.1993","volume":"13","author":"G Manfioletti","year":"1993","unstructured":"Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol. 1993;13(8):4976\u201385. https:\/\/doi.org\/10.1128\/mcb.13.8.4976-4985.1993.","journal-title":"Mol Cell Biol"},{"key":"6398_CR152","doi-asserted-by":"publisher","unstructured":"Au N, Lg Y. Galectin-3--a jack-of-all-trades in cancer. Cancer Lett. 2011;313(2). https:\/\/doi.org\/10.1016\/j.canlet.2011.09.003","DOI":"10.1016\/j.canlet.2011.09.003"},{"issue":"12","key":"6398_CR153","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1128\/MCB.15.12.6582","volume":"15","author":"L Ling","year":"1995","unstructured":"Ling L, Kung HJ. Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase. Mol Cell Biol. 1995;15(12):6582\u201392. https:\/\/doi.org\/10.1128\/MCB.15.12.6582.","journal-title":"Mol Cell Biol"},{"key":"6398_CR154","doi-asserted-by":"publisher","unstructured":"Mm G, Kh K, T S, C Z, H H. Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB. Mol Cell Biol. 1999;19(2). https:\/\/doi.org\/10.1128\/MCB.19.2.1171","DOI":"10.1128\/MCB.19.2.1171"},{"issue":"8","key":"6398_CR155","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537\u201349. https:\/\/doi.org\/10.1038\/nrc2694.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"6398_CR156","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/acs.jmedchem.4c00148","volume":"67","author":"D Kong","year":"2024","unstructured":"Kong D, Tian Q, Chen Z, et al. Discovery of Novel Macrocyclic MERTK\/AXL Dual Inhibitors. J Med Chem. 2024;67(7):5866\u201382. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00148.","journal-title":"J Med Chem"},{"issue":"47","key":"6398_CR157","doi-asserted-by":"publisher","first-page":"30022","DOI":"10.1074\/jbc.271.47.30022","volume":"271","author":"K Nagata","year":"1996","unstructured":"Nagata K, Ohashi K, Nakano T, et al. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem. 1996;271(47):30022\u20137. https:\/\/doi.org\/10.1074\/jbc.271.47.30022.","journal-title":"J Biol Chem"},{"issue":"39","key":"6398_CR158","doi-asserted-by":"publisher","first-page":"22681","DOI":"10.1074\/jbc.270.39.22681","volume":"270","author":"K Ohashi","year":"1995","unstructured":"Ohashi K, Nagata K, Toshima J, et al. Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6. J Biol Chem. 1995;270(39):22681\u20134. https:\/\/doi.org\/10.1074\/jbc.270.39.22681.","journal-title":"J Biol Chem"},{"key":"6398_CR159","doi-asserted-by":"crossref","unstructured":"Dahlb\u00e4ck B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost. 1995;74(1):139\u2013148.","DOI":"10.1055\/s-0038-1642667"},{"issue":"7","key":"6398_CR160","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jtho.2023.02.016","volume":"18","author":"K He","year":"2023","unstructured":"He K, Berz D, Gadgeel SM, et al. MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2023;18(7):907\u201321. https:\/\/doi.org\/10.1016\/j.jtho.2023.02.016.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"2","key":"6398_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.11.024","volume":"433","author":"R Arya","year":"2021","unstructured":"Arya R, Kumari S, Pandey B, et al. Structural insights into SARS-CoV-2 proteins. J Mol Biol. 2021;433(2): 166725. https:\/\/doi.org\/10.1016\/j.jmb.2020.11.024.","journal-title":"J Mol Biol"},{"key":"6398_CR162","doi-asserted-by":"publisher","unstructured":"V\u2019kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155\u2013170. https:\/\/doi.org\/10.1038\/s41579-020-00468-6","DOI":"10.1038\/s41579-020-00468-6"},{"key":"6398_CR163","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.csbj.2024.01.009","volume":"23","author":"MHH Shum","year":"2024","unstructured":"Shum MHH, Lee Y, Tam L, et al. Binding affinity between coronavirus spike protein and human ACE2 receptor. Comput Struct Biotechnol J. 2024;23:759\u201370. https:\/\/doi.org\/10.1016\/j.csbj.2024.01.009.","journal-title":"Comput Struct Biotechnol J"},{"issue":"4","key":"6398_CR164","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562\u20139. https:\/\/doi.org\/10.1038\/s41564-020-0688-y.","journal-title":"Nat Microbiol"},{"issue":"4","key":"6398_CR165","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.chom.2012.08.009","volume":"12","author":"L Meertens","year":"2012","unstructured":"Meertens L, Carnec X, Lecoin MP, et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe. 2012;12(4):544\u201357. https:\/\/doi.org\/10.1016\/j.chom.2012.08.009.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"6398_CR166","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1128\/JVI.03287-13","volume":"88","author":"K Morizono","year":"2014","unstructured":"Morizono K, Chen ISY. Role of phosphatidylserine receptors in enveloped virus infection. J Virol. 2014;88(8):4275\u201390. https:\/\/doi.org\/10.1128\/JVI.03287-13.","journal-title":"J Virol"},{"key":"6398_CR167","doi-asserted-by":"publisher","first-page":"1394429","DOI":"10.3389\/fimmu.2024.1394429","volume":"15","author":"J You","year":"2024","unstructured":"You J, Huang R, Zhong R, et al. Serum AXL is a potential molecular marker for predicting COVID-19 progression. Front Immunol. 2024;15:1394429. https:\/\/doi.org\/10.3389\/fimmu.2024.1394429.","journal-title":"Front Immunol"},{"issue":"1","key":"6398_CR168","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12951-024-02435-2","volume":"22","author":"JY Fang","year":"2024","unstructured":"Fang JY, Huang KY, Wang TH, et al. Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19. J Nanobiotechnology. 2024;22(1):169. https:\/\/doi.org\/10.1186\/s12951-024-02435-2.","journal-title":"J Nanobiotechnology"},{"key":"6398_CR169","doi-asserted-by":"publisher","unstructured":"Oliveira KX, Suzuki YJ. Angiotensin peptides enhance SARS-CoV-2 spike protein binding to its host cell receptors. BioRxiv Prepr Serv Biol. Published online December 13, 2024:2024.12.12.628247. https:\/\/doi.org\/10.1101\/2024.12.12.628247","DOI":"10.1101\/2024.12.12.628247"},{"issue":"8","key":"6398_CR170","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/biom11081136","volume":"11","author":"B Ku\u015bnierz-Cabala","year":"2021","unstructured":"Ku\u015bnierz-Cabala B, Maziarz B, Dumnicka P, et al. Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study. Biomolecules. 2021;11(8):1136. https:\/\/doi.org\/10.3390\/biom11081136.","journal-title":"Biomolecules"},{"issue":"4","key":"6398_CR171","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/biomedicines9040335","volume":"9","author":"A Morales","year":"2021","unstructured":"Morales A, Rojo Rello S, Crist\u00f3bal H, et al. Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome. Biomedicines. 2021;9(4):335. https:\/\/doi.org\/10.3390\/biomedicines9040335.","journal-title":"Biomedicines"},{"issue":"10","key":"6398_CR172","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200674","volume":"217","author":"T Zhou","year":"2020","unstructured":"Zhou T, Su TT, Mudianto T, Wang J. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies. J Exp Med. 2020;217(10): e20200674. https:\/\/doi.org\/10.1084\/jem.20200674.","journal-title":"J Exp Med"},{"key":"6398_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109418","volume":"116","author":"R Hirawat","year":"2023","unstructured":"Hirawat R, Jain N, Aslam Saifi M, Rachamalla M, Godugu C. Lung fibrosis: Post-COVID-19 complications and evidences. Int Immunopharmacol. 2023;116: 109418. https:\/\/doi.org\/10.1016\/j.intimp.2022.109418.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"6398_CR174","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438\u201340. https:\/\/doi.org\/10.1016\/S2352-3026(20)30145-9.","journal-title":"Lancet Haematol"},{"issue":"10229","key":"6398_CR175","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Lond Engl. 2020;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"6398_CR176","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","volume":"76","author":"I Paranjpe","year":"2020","unstructured":"Paranjpe I, Fuster V, Lala A, et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. J Am Coll Cardiol. 2020;76(1):122\u20134. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.001.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"6398_CR177","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1172\/JCI39325","volume":"119","author":"T Burstyn-Cohen","year":"2009","unstructured":"Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest. 2009;119(10):2942\u201353. https:\/\/doi.org\/10.1172\/JCI39325.","journal-title":"J Clin Invest"},{"issue":"7","key":"6398_CR178","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41577-020-0354-x","volume":"20","author":"G Lemke","year":"2020","unstructured":"Lemke G, Silverman GJ. Blood clots and TAM receptor signalling in COVID-19 pathogenesis. Nat Rev Immunol. 2020;20(7):395\u20136. https:\/\/doi.org\/10.1038\/s41577-020-0354-x.","journal-title":"Nat Rev Immunol"},{"key":"6398_CR179","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cytogfr.2021.10.007","volume":"63","author":"F Ahmad","year":"2022","unstructured":"Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev. 2022;63:58\u201368. https:\/\/doi.org\/10.1016\/j.cytogfr.2021.10.007.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"6398_CR180","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/ejh.13501","volume":"105","author":"RM Mart\u00edn-Rojas","year":"2020","unstructured":"Mart\u00edn-Rojas RM, P\u00e9rez-Rus G, Delgado-Pinos VE, et al. COVID-19 coagulopathy: An in-depth analysis of the coagulation system. Eur J Haematol. 2020;105(6):741\u201350. https:\/\/doi.org\/10.1111\/ejh.13501.","journal-title":"Eur J Haematol"},{"key":"6398_CR181","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fmed.2018.00137","volume":"5","author":"LA Law","year":"2018","unstructured":"Law LA, Graham DK, Di Paola J, Branchford BR. GAS6\/TAM Pathway Signaling in Hemostasis and Thrombosis. Front Med. 2018;5:137. https:\/\/doi.org\/10.3389\/fmed.2018.00137.","journal-title":"Front Med"},{"key":"6398_CR182","doi-asserted-by":"publisher","unstructured":"Shepard RM, Ghebremedhin A, Pratumchai I, et al. PI3K\u03b3 inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections. Sci Transl Med. 2024;16(754):eadi6887. https:\/\/doi.org\/10.1126\/scitranslmed.adi6887","DOI":"10.1126\/scitranslmed.adi6887"},{"issue":"10223","key":"6398_CR183","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet Lond Engl. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"China Lancet Lond Engl"},{"key":"6398_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155323","volume":"137","author":"A Ghazavi","year":"2021","unstructured":"Ghazavi A, Ganji A, Keshavarzian N, Rabiemajd S, Mosayebi G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 2021;137: 155323. https:\/\/doi.org\/10.1016\/j.cyto.2020.155323.","journal-title":"Cytokine"},{"issue":"6","key":"6398_CR185","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","volume":"131","author":"CV Rothlin","year":"2007","unstructured":"Rothlin CV, Ghosh S, Zuniga EI, Oldstone MBA, Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007;131(6):1124\u201336. https:\/\/doi.org\/10.1016\/j.cell.2007.10.034.","journal-title":"Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06398-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T05:32:47Z","timestamp":1745645567000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06398-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6398"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06398-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}